https://www.selleckchem.com/pr....oducts/cl-387785-eki
Only five confirmed COVID-19 cases were registered (2.1%), all of them of mild severity. One hundred and fifty-five patients participated in the survey (77 on intravenous and 78 on subcutaneous drugs). Fear of going to the hospital was the most common reason for postponing biological administrations. Among those on combination therapy, only 7% admitted to have withdrawn immunosuppressants. Adherence to intravenous and subcutaneous biological therapies during the pandemic was high in a single-center cohort of IBD patients even
Like
Comment
Share
